Stock Price
2.71
Daily Change
3.44%
Yearly
-12.86%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Astellas Pharma 1,763.50 -16.00 -0.90% 17.41%
Acadia Pharmaceuticals 19.20 0.36 1.91% -66.19%
Agios Pharmaceuticals 35.62 0.11 0.31% -23.46%
Akebia Therapeutics 2.71 0.09 3.44% -12.86%
Alnylam Pharmaceuticals 183.80 3.06 1.69% 38.96%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 198.88 -4.59 -2.26% -11.64%
Ardelyx 1.14 0.28 32.24% -81.40%
Avrobio Inc 3.84 -0.13 -3.27% -72.11%
AstraZeneca 8,314.00 38.00 0.46% 4.75%
Bayer 44.93 0.41 0.91% -6.06%
BioMarin Pharmaceutical 86.29 -1.11 -1.27% 8.54%
Exelixis 16.79 -0.12 -0.71% -12.37%
Fresenius Medical Care 53.30 0.52 0.99% -23.22%
GlaxoSmithKline 1,528.60 3.60 0.24% 9.69%
Intercept Pharmaceuticals 17.21 0.78 4.75% -51.78%
Ionis Pharmaceuticals 26.50 -0.95 -3.46% -48.16%
Ironwood Pharmaceuticals 11.09 0.23 2.12% -6.57%
J&J 155.93 -3.82 -2.39% 5.75%
Karyopharm Therapeutics 6.95 0.10 1.46% -58.92%
Lexicon Pharmaceuticals 4.58 -0.08 -1.72% 213.70%
Moderna Inc 352.43 -16.08 -4.36% 149.93%
Nektar Therapeutics 11.26 0.15 1.35% -31.63%
Opko Health 3.93 -0.16 -3.91% -7.96%
Prothena 50.15 0.93 1.89% 355.91%
PTC Therapeutics 37.16 0.27 0.73% -40.82%
Regeneron Pharmaceuticals 636.53 -17.87 -2.73% 23.82%
Roche Holding 363.15 3.50 0.97% 19.99%
Sanofi 84.55 0.69 0.82% 0.61%
Seattle Genetics 160.00 -5.31 -3.21% -9.81%
Sarepta Therapeutics 80.81 0.95 1.19% -44.63%
Vanda Pharmaceuticals 16.20 -0.67 -3.97% 31.28%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%

Indexes Price Day Year
NASDAQ 15538 -245.14 -1.55% 25.76%
US2000 2199 -43.07 -1.92% 19.76%

Akebia Therapeutics
Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on producing medicines for people living with kidney disease. Its lead product candidate, vadadustat, is an oral therapy in development for the treatment of anemia due to chronic kidney disease (CKD). Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), designed to mimic the physiologic effect of altitude on oxygen availability. In addition, it has a commercial product, Auryxia (ferric citrate), which is marketed for two indications in the United States: the control of serum phosphorus levels in dialysis-dependent (DD)-CKD adult patients and the treatment of iron deficiency anemia (IDA), in non-dialysis dependent (NDD)-CKD adult patients. Ferric citrate is also approved and marketed in Japan as an oral treatment for the improvement of hyperphosphatemia in patients with CKD.